Health Care: Drugs

Aastrom Biosciences Inc (ASTM: NASDAQ)

$3.16 -0.09 | -2.77%
07/31/14 - 03:58 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 19.00K 21.00K 18.00K 253.00K
Cost of Sales 4.00K 6.00K 4.00K 2.00K
Gross Operating Profit 15.00K 15.00K 14.00K 251.00K
Selling, General, and Administrative Expenses 5.88M 7.75M 7.72M 3.26M
Research & Development 15.10M 26.02M 21.33M 8.61M
Operating Income before D & A (EBITDA) -20.96M -33.76M -29.04M -11.62M
Depreciation & Amortization 489.00K 649.00K 647.00K 259.00K
Interest Income 16.00K 50.00K 53.00K 40.00K
Other Income - Net 5.34M 4.25M 9.33M -7.50M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -16.10M -30.11M -20.30M -19.34M
Interest Expense 11.00K 12.00K 10.00K 5.00K
Pre-Tax Income -16.11M -30.12M -20.32M -19.35M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -15.62M -29.47M -19.67M -19.09M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -15.62M -29.47M -19.67M -19.09M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -15.62M -29.47M -19.67M -19.09M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-15.62M -29.47M -19.67M -19.09M
Preferred Dividends
Net Income Available To Common -15.62M -33.47M -19.67M -19.09M
Basic EPS from Continuing Ops. -5.18 -16.20 -10.20 -13.00
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -5.18 -16.20 -10.20 -13.00
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) -1.77 0.00 0.00 0.00
Basic EPS, Total -6.95 -16.20 -10.20 -13.00
Basic Normalized Net Income/Share -5.18 -16.20 -10.20 -13.00
EPS fr Continuing Ops. -5.18 -16.20 -10.20 -13.00
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -5.18 -16.20 -10.20 -13.00
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) -1.77 0.00 0.00 0.00
EPS, Total -6.95 -16.20 -10.20 -13.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-5.18 -16.20 -10.20 -13.00
Dividends Paid per Share 0.00 0.00 0.00 0.00
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter